HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Microbead Bill Passes Congress Without Biodegradable Plastic Exemption

This article was originally published in The Rose Sheet

Executive Summary

The Senate passed the Microbead-Free Waters Act December 18, following House clearance earlier this month. With President Obama's signature, the legislation will establish national uniformity in cosmetic microbead regulation and a feasible phase-out schedule, but use of PHA-based microbeads, sought by manufacturers as a highly adaptable replacement option, ostensibly will not be permitted in the US.

You may also be interested in...



2021 Could Be Start Of Global Beauty Microplastic Purge

The European Union’s deliberations in 2021 on a proposed microplastic restriction will determine exactly what and when microplastic ingredients must be removed from cosmetic products on the EU market, likely with global ripple effects.

EU’s Microplastic Clampdown Has Echoes Of US MFWA; Will Bioplastics Be Left Out In The Cold Again?

The future of microplastics use in the European cosmetics sector hangs in the balance as legislative efforts move forward in line with the Commission’s Plastics Strategy released in January. A key question is whether next-generation, biodegradable plastics will get caught up in any bans that transpire, limiting manufacturers’ options and dashing the hopes of emerging producers with cosmetic interests.

Hawaii’s Sunscreen Ingredient Ban Is On The Books; To Industry, An Affront To Science

As in the case of plastic microbeads some four years ago, the personal-care industry finds itself in the position of having to reformulate potentially on a mass scale due to environmental rather than human safety concerns. And once again the legislation was driven in large part by shoddy science, industry says.

Related Content

Related Companies

UsernamePublicRestriction

Register

RS019774

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel